CSM2, PSY3, SHU1, and SHU2 (collectively referred to as the SHU genes) were identified in Saccharomyces cerevisiae as four genes in the same epistasis group that suppress various sgs1 and top3 mutant phenotypes when mutated. Although the SHU genes have been implicated in homologous recombination repair (HRR), their precise role(s) within this pathway remains poorly understood. Here, we have identified a specific role for the Shu proteins in a Rad51/Rad54-dependent HRR pathway(s) to repair MMS-induced lesions during S-phase. We show that, although mutation of RAD51 or RAD54 prevented the formation of MMS-induced HRR intermediates (X-molecules) arising during replication in sgs1 cells, mutation of SHU genes attenuated the level of these structures. Similar findings were also observed in shu1 cells in which Rmi1 or Top3 function was impaired. We propose a model in which the Shu proteins act in HRR to promote the formation of HRR intermediates that are processed by the Sgs1-Rmi1-Top3 complex.
INTRODUCTIONHomologous recombination repair (HRR) is a well-conserved cellular process for the repair of single-strand DNA (ssDNA) gaps and double-strand DNA breaks (DSBs) that can arise during DNA synthesis or as a result of replication fork stalling during S-phase. Although many of the key proteins involved in HRR have been identified (reviewed in Paques and Haber, 1999;Sung et al., 2003;West, 2003;Krogh and Symington, 2004), in some cases their precise function(s) remains to be identified. Moreover, the mechanisms for suppression of inappropriate HRR in S-phase are only poorly defined. It is likely that HRR must be carefully regulated and/or executed in dividing cells, as inappropriate or excessive HR can lead to genome rearrangements and cancer in mammals. This is exemplified by the cancer-predisposition disorder, Bloom's syndrome, which is caused by mutation in the human BLM gene (reviewed in German, 1993). Because the BLM protein, in conjunction with its associated proteins, hTOPOIII␣ and hRMI1 (Johnson et al., 2000;Wu et al., 2000;Yin et al., 2005), can catalyze dissolution of HRR intermediates in vitro Plank et al., 2006;Raynard et al., 2006;Wu et al., 2006), it is likely that unprocessed and/or aberrantly processed HRR intermediates at least partly contribute to the cellular defects in Bloom's syndrome. Indeed, Bloom's syndrome cells classically demonstrate elevated levels of sister chromatid exchanges, mitotic recombination, and genome instability. Mutation of the BLM, hTOPOIII␣, or hRMI1 homologues in Saccharomyces cerevisiae (SGS1, TOP3, or RMI1, respectively) similarly causes sensitivity to genotoxic agents, hyper-recombination, and synthetic lethality with mutations in other genes also implicated in HRR (e.g., MUS81 and SRS2; Gangloff et al., 1994;Watt et al., 1996;Gangloff et al., 2000;Mullen et al., 2001;Fabre et al., 2002;Chang et al., 2005;Mullen et al., 2005). Furthermore, unresolved HRR intermediates have been directly visualized by two-dimensional (2D) gel electrophoresis in cells lacking Sgs1 or in cells w...